Back Home Search

Non-Production - RAS, MEK, or NF1 driver mutated gynecologic cancer

  • Gynecologic cancer1
  • KRAS G12C in NSCLC and CRC1
  • Protocols

  • UW23105

    OPEN TO ACCRUAL

    Ph 1/2 Study of DCC-3116 w/ RAS/MAPK Pathway Inhibitors in Pts w/ Solid Tumors w/ RAS/MAPK Mutations